Drug ID: | NPD8109 |
Drug Name: | THRX-198321 |
Molecular Formula: | C38H48N4O5 |
Canonical SMILES: | OC(=Nc1ccccc1c1ccccc1)OC1CCN(CC1)CCCCCCCCCNC[C@@H](c1ccc(c2c1ccc(n2)O)O)O |
Standard InCHI: | InChI=1S/C38H48N4O5/c43-34-19-17-31(32-18-20-36(45)41-37(32)34)35(44)27-39-23-11-4-2-1-3-5-12-24-42-25-21-29(22-26-42)47-38(46)40-33-16-10-9-15-30(33)28-13-7-6-8-14-28/h6-10,13-20,29,35,39,43-44H,1-5,11-12,21-27H2,(H,40,46)(H,41,45)/t35-/m0/s1 |
Standard InCHIKey: | NVEMUJANQDPDSC-DHUJRADRSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DCL000397; DIB001435 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 9874175 |
ChEBI | |
CAS Number |
Molecular Weight | 640.36 |
ALogP | -3.9537 |
MLogP | 4.65 |
XLogP | 9.377 |
HDA | 7 |
HBD | 5 |
Rotatable Bonds | 21 |
TPSA | 130.67 |
RO5 Violation | 2 |